← Eichor
Condition: Leptomeningeal Metastasis Of Breast Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Leptomeningeal Metastasis Of Breast Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Canc
Phase 1/Phase 2 · 1 location(s) · Guangzhou Medical University · NCT06462092Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Methotrexate in Breast Cancer With Lep
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06543992Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell
Phase 2 · 2 location(s) · City of Hope Medical Center · NCT06910761Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis
Phase 4 · 1 location(s) · Fudan University · NCT06230055Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-
Phase 3 · 58 location(s) · NRG Oncology · NCT06500481Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer
NA · 1 location(s) · Mayo Clinic · NCT05746325Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Phase 2 · 3 location(s) · Wake Forest University Health Sciences · NCT02422641Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or N
Phase 2 · 2 location(s) · University of Washington · NCT06518057Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
Phase 2 · 11 location(s) · UNICANCER · NCT05800275Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases
Phase 1/Phase 2 · 2 location(s) · Fudan University · NCT07134153Study in Patients With Breast Cancer Leptomeningeal Metastasis
Phase N/A · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06638294Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab in Breast Cancer With Lept
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07263425A Phase IIa Study to Evaluate NBQ72S
Phase 2 · 1 location(s) · Nantong Bencao Quadriga Medical Technology Co. Ltd. · NCT06810804
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.